Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenwei Shen

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|July 28, 2018
Pharmacokinetics and safety profile of desmopressin oral tablet formulations in healthy Chinese subjects under fasting and fed conditionsXiaojiao Li, Hong Zhang, Xiaoxue Zhu, et al.
Clinical Pharmacology in Drug Development|September 26, 2019
Clinical Evaluation of the Tolerability and Pharmacokinetics of Azilsartan, a Potent Angiotensin Receptor Blocker, in Healthy Chinese SubjectsXiaojiao Li, Jingrui Liu, Changcheng Sheng, et al.
Vaccine|December 21, 2016
Evaluation of a candidate live attenuated influenza vaccine prepared in Changchun BCHT (China) for safety and efficacy in ferretsZhenwei Shen, Richard A Bowen, Peng Ge, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 18, 2018
Evaluation of reference-scaled average bioequivalence of two oral formulations of abiraterone acetate in healthy Chinese subjects
Cuiyun Li, Yanhua Ding, Deming Yang, et al.
Clinical & Developmental Immunology|April 5, 2012
Protection against SHIV-KB9 infection by combining rDNA and rFPV vaccines based on HIV multiepitope and p24 protein in Chinese rhesus macaquesChang Li, Zhenwei Shen, Xiao Li, et al.
The Journal of Pharmacy and Pharmacology|April 10, 2018
Clinical evaluation of efficacy, tolerability and pharmacokinetics of yimitasvir phosphate in patients infected with hepatitis C virusHong Zhang, Xiaoxue Zhu, Qingmei Li, et al.
Cancer|June 7, 2023
Efficacy and safety of pralsetinib in patients with advanced RET fusion-positive non-small cell lung cancerQing Zhou, Jun Zhao, Jianhua Chang, et al.
Endocrine-Related Cancer|January 23, 2024
Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patientsXiangqian Zheng, Meiyu Fang, Yun Fan, et al.
JAMA|February 24, 2025
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer: The GEMSTONE-303 Randomized Clinical TrialXiaotian Zhang, Jufeng Wang, Gang Wang, et al.
Blood Science (Baltimore, Md.)|June 24, 2024
Ivosidenib in Chinese patients with relapsed or refractory isocitrate dehydrogenase 1 mutated acute myeloid leukemia: a registry studyMingyuan Sun, Qingsong Yin, Yang Liang, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Clinical Pharmacology and Therapeutics|July 28, 2018
Pharmacokinetics and safety profile of desmopressin oral tablet formulations in healthy Chinese subjects under fasting and fed conditionsXiaojiao Li, Hong Zhang, Xiaoxue Zhu, et al.
Clinical Pharmacology in Drug Development|September 26, 2019
Clinical Evaluation of the Tolerability and Pharmacokinetics of Azilsartan, a Potent Angiotensin Receptor Blocker, in Healthy Chinese SubjectsXiaojiao Li, Jingrui Liu, Changcheng Sheng, et al.
Vaccine|December 21, 2016
Evaluation of a candidate live attenuated influenza vaccine prepared in Changchun BCHT (China) for safety and efficacy in ferretsZhenwei Shen, Richard A Bowen, Peng Ge, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 18, 2018
Evaluation of reference-scaled average bioequivalence of two oral formulations of abiraterone acetate in healthy Chinese subjects
Cuiyun Li, Yanhua Ding, Deming Yang, et al.
Clinical & Developmental Immunology|April 5, 2012
Protection against SHIV-KB9 infection by combining rDNA and rFPV vaccines based on HIV multiepitope and p24 protein in Chinese rhesus macaquesChang Li, Zhenwei Shen, Xiao Li, et al.
The Journal of Pharmacy and Pharmacology|April 10, 2018
Clinical evaluation of efficacy, tolerability and pharmacokinetics of yimitasvir phosphate in patients infected with hepatitis C virusHong Zhang, Xiaoxue Zhu, Qingmei Li, et al.
Cancer|June 7, 2023
Efficacy and safety of pralsetinib in patients with advanced RET fusion-positive non-small cell lung cancerQing Zhou, Jun Zhao, Jianhua Chang, et al.
Endocrine-Related Cancer|January 23, 2024
Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patientsXiangqian Zheng, Meiyu Fang, Yun Fan, et al.
JAMA|February 24, 2025
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer: The GEMSTONE-303 Randomized Clinical TrialXiaotian Zhang, Jufeng Wang, Gang Wang, et al.
Blood Science (Baltimore, Md.)|June 24, 2024
Ivosidenib in Chinese patients with relapsed or refractory isocitrate dehydrogenase 1 mutated acute myeloid leukemia: a registry studyMingyuan Sun, Qingsong Yin, Yang Liang, et al.
Pageof 4